Press Releases
Home › Press Releases
The news index is intended for investors and media professionals who are looking to learn more about Angiotech. We hope you find this information useful and if you can't find what you are looking for, please feel free to contact us.
All press releases and other information listed below were, to the best of Angiotech's knowledge, timely and accurate when issued. However, the passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. Angiotech does not assume the obligation to update this information. All viewers should carefully check the dates of issuance of the material contained in the Angiotech site.
2010
- July 30Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2010
- July 28Angiotech Pharmaceuticals and Partner Athersys Announce Positive Results from Phase I Study of MultiStem® in Heart Attack Patients
- July 8Angiotech Pharmaceuticals Announces Notice of Failure to Satisfy a Continued Listing Rule with the Nasdaq Stock Market
- June 24Angiotech Pharmaceuticals Announces Conference Call and Webcast for Second Quarter 2010 Financial Results
- June 11Angiotech's Licensee, Cook Medical, Files PMA Submission for FDA Approval of Zilver® PTX® Drug-Eluting Stent Platform
- June 10Angiotech Pharmaceuticals Announces Acceptance of 2010 Medical Device Excellence Award for Quill™ SRS
- June 10Angiotech Pharmaceuticals Announces European Launch and First Implants of Boston Scientific Corporation's Platinum Chromium TAXUS® Element™ Stent System
- May 25Angiotech's Licensee, Cook Medical, Announces Single-Arm Study Reveals 86.2 Percent SFA Vessel Patency For Zilver® PTX™
- May 20Angiotech Announces Date of Annual and Special General Meeting of Shareholders
- May 12Angiotech Pharmaceuticals Announces European Approval of Boston Scientific Corporation's Platinum Chromium TAXUS® Element™ Stent System
- May 4Angiotech Pharmaceuticals, Inc. Announces Financial Results for the First Quarter Ended March 31, 2010
- May 3Angiotech Announces Exclusive Distribution Agreement with B. Braun for Angiotech's Proprietary Quill™ SRS Product Line
- April 21Angiotech's Licensee, Cook Medical, Enrolls First Renal Artery Disease Patient in Clinical Trial of New Drug-Eluting Stent
- April 7Notice of Conference Call and Webcast: First Quarter 2010 Financial Results
- April 7Angiotech Closes Acquisition of Certain Product Candidates and Technology Assets of Haemacure Corporation
- March 16Study Shows Superior Efficacy for TAXUS® Express® Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
- March 15Angiotech Pharmaceuticals Announces PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific's Novel Platinum Chromium TAXUS® Element™ Stent System
- March 4Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Fourth Quarter Ended December 31, 2009
- February 17Angiotech Pharmaceuticals and Partner Athersys Announces Completion of Patient Enrollment in Phase I Study of MultiStem® in Acute Mycardial Infarction
- February 4Notice of Conference Call and Webcast: Fourth Quarter and Year End 2009 Financial Results
News
Quick Links
© Copyright 2010 Angiotech. All Rights Reserved.